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Background: The TRAMIL program aims to understand, validate and expand health practices based on the use of
medicinal plants in the Caribbean, which is a “biodiversity hotspot” due to high species endemism, intense
development pressure and habitat loss. The antibacterial activity was examined for thirteen plant species from
several genera that were identified as a result of TRAMIL ethnopharmacological surveys or were reported in
ethnobotanical accounts from Puerto Rico. The aim of this study was to validate the traditional use of these plant
species for the treatment of bacterial infections, such as conjunctivitis, fever, otitis media and furuncles.
Methods: An agar disc diffusion assay was used to examine five bacterial strains that are associated with the
reported infections, including Staphylococcus saprophyticus (ATCC 15305), S. aureus (ATCC 6341), Escherichia coli
(ATCC 4157), Haemophilus influenzae (ATCC 8142), Pseudomonas aeruginosa (ATCC 7700) and Proteus vulgaris
(ATCC 6896), as well as the fungus Candida albicans (ATCC 752). The minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC) values were determined for each of the extracts that showed inhibitory
activity.
Results: The decoctions of Pityrogramma calomelanos, Tapeinochilus ananassae, and Syzygium jambos, as well as the
juice of Gossypium barbadense, showed > 20% growth inhibition against several bacteria relative to the positive
control, which was the antibiotic Streptomycin. Extracts with the best antimicrobial activities were S. jambos that
showed MIC = 31 μg/mL and MBC = 1.0 mg/mL against P. vulgaris and T. ananassae that showed MIC = 15 μg/mL
against S. aureus.
Conclusion: This report confirms the traditional use of P. calomelanos for the treatment of kidney infections that
are associated with stones, as well as the antimicrobial and bactericidal effects of T. ananassae against P. vulgaris
and S. saprophyticus and the effects of S. jambos against S. aureus and S. saprophyticus.
Keywords: Ethnopharmacology, TRAMIL, Antibacterial, Syzygium jambos, Pityrogramma calomelanos, Tapeinochilus
ananassae, Gossypium barbadenseBackground
The plant-based formulations are a viable option that
could be useful in reducing the side effects associated
with conventional antibiotic treatment [1]. Plant-based
formulations would also increase the number of com-
pounds that are used to limit infections [2] and might
function synergistically with current therapies [3]. Many* Correspondence: jannette.gavillan@upr.edu
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distribution, and reproduction in any mediumreports have identified anti-bacterial properties of plants,
but these studies have primarily been conducted in Asia
[4]. The Caribbean is one of the world’s centers of
biodiversity and endemism identified as a tropical moun-
tainous “biodiversity hotspot” because “high species en-
demism combines with proportionally extensive habitat
loss” [5]. Information regarding the use of herbal remed-
ies in the Caribbean was obtained during TRAMIL
(Traditional Medicines in the Islands) surveys. TRAMIL,
which is a program of applied research focusing on
popular medicine, was initiated in 1982 to understand,
validate and expand primary health care practices based
on the use of medicinal plants in the Caribbean. Theed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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consists of ethnopharmacological surveys and biblio-
graphic and experimental research. The TRAMIL pro-
gram works to validate plant species, plant organs and
methods of preparation that are recorded during
TRAMIL surveys and that are used frequently, 20% or
more, for a particular ailment but are not documented
in the scientific literature. The scientific validation of
traditional health practices is based on criteria of safety
and efficacy [6,7]. Moreover, TRAMIL organizes out-
reach activities (TRADIF) that are aimed at disseminat-
ing the results obtained from the efficacy and toxicity
studies. Thus, the objectives and experience of TRAMIL
in traditional Caribbean knowledge and the sustainable
utilization of plants appear to be the best starting point
to find interesting plants with antimicrobial potential.
In addition, plant species described in ethnobotanical
accounts from Puerto Rico that are used to treat infec-
tions and as adjuvants for diabetes were included in this
study [8,9]. There is evidence that diabetic patients suf-
fer from high bacteremia levels due to high blood sugar
levels that weaken the patient’s immune system defenses
[10] and increase the body’s vulnerability to bacterial
infections [11,12]. Consequently, the aim of this study
was to validate the antimicrobial activity of herbal rem-
edies that are used in the Caribbean to treat infections
such as conjunctivitis, otitis media, kidney infections,
and furuncles.
Methods
Plant collection and identification
All of the plants were collected in Puerto Rico. The
specimens were numbered and deposited at the George
Proctor Herbarium (SJ) in Puerto Rico. José Sustache,
Botanist and Head of Puerto Rico Department of Nat-
ural and Environmental Resources Herbarium, classified
the botanical species. The plant species that have been
identified in the TRAMIL program and their traditional
uses are the focus of the current study and are shown in
Table 1.
Plant material and preparation of decoctions, juices and
aqueous extracts
Decoctions were prepared by boiling 30 g of plant ma-
terial in 100 mL of distilled water. After concentration
to 15 mL, to lyophilize 3 × 5 mL replicates, the decoc-
tions were filtered through cheesecloth, and freeze-dried
using a Freezone 4.5 lyophilizer. Plant juices (3 × 5 mL
replicates) were lyophilized after the plant part was
crushed in a mortar and filtered through cheesecloth.
The solids obtained after freeze-drying were re-dissolved
in autoclaved water to known concentrations for anti-
bacterial determination. The concentrations of the ly-
ophilized extracts in mg/mL were calculated as theaverage of the total solids obtained per mL of lyophilized
decoction or plant juice. The plant part, preparation
form, concentration of the re-dissolved extracts and the
extraction yields are reported in Table 1.Disc preparation
Whatman chromatography no 2 filter paper was used to
prepare 6.3 mm paper discs that were incubated with 20 μL
aliquots of the re-dissolved extracts from lyophilized decoc-
tions or juices at their final concentration and at 25% and
50% dilutions, and air-dried for 2 hours, as described
previously [13]. The positive controls were Streptomycin
(5 mg/mL) and Nystatin (50 mg/L) for the antibacterial and
antifungal assays, respectively. Distilled water was used as a
negative control. The concentration of the extracts in the
paper discs is reported in Table 1.Bacterial selection and culture
The Caribbean Herbal Pharmacopeia [6], which is pub-
lished by the TRAMIL program, established the experi-
mental models that are required to validate antimicrobial
activity. In this case, the antimicrobial activity had to be
confirmed for at least one case. For agents associated with
bacterial conjunctivitis, TRAMIL requires in vitro suscep-
tibility studies of Haemophilus influenzae, Streptococcus
pneumonia or Staphylococcus aureus. For otitis media,
TRAMIL recommends the analysis of the effects of herbal
remedies against the Gram-negative bacteria Escherichia
coli, Pseudomonas aeruginosa or Proteus vulgaris; the
Gram-positive bacterium S. aureus; and the fungus
Candida albicans. E. coli is the primary causal agent of
urinary tract infections (UTIs) and accounts for > 75% of
community-acquired UTIs in all age groups, whereas
Staphylococcus saprophyticus accounts for 10% of total
UTIs [14]. Infections due to the presence of kidney stones
are more commonly caused by urease-producing bacteria,
such as S. aureus, Pseudomonas and Proteus. Finally, in
the case of furuncle, which is an infection of the hair fol-
licle, TRAMIL requires validation of antimicrobial activity
against S. aureus.
The test organisms included the Gram-positive bac-
teria Staphylococcus saprophyticus (ATCC 15305) and
Staphylococcus aureus (ATCC 6341); the Gram-negative
bacteria Escherichia coli (ATCC 4157), Haemophilus
influenzae (ATCC 8142), Pseudomonas aeruginosa
(ATCC 7700), and Proteus vulgaris (ATCC 6896); and
the fungus Candida albicans (ATCC 752). The bacteria
were maintained at 4°C on tryptic soy agar (TSA), and
C. albicans (ATCC 752) was maintained on potato
dextrose agar (PDA) (Difco, NJ, USA) before use. H. in-
fluenza (ATCC 8142) was incubated in the presence of
a Gas-Pac (Becton and Dickinson Co, NJ, USA) with 5%
CO2.
Table 1 Plant species recorded in ethnopharmacological/ethnobotanical surveys in the Caribbean that were examined




















































































Puerto Rico/psoriasis sanguinaria leaves/decoction 2.8 56.0 56.0 28.0 14.0
Zingiberaceae Costus
specious (J. König) Sm.
c,d (019660)
Puerto Rico/nephritis caña amarga,
insulina









Puerto Rico Pomarrosa del río leaves/decoction 2.1 41.8 41.8 20.9 10.5
a) Reported in 20% or more of the interviews for a given ailment.
b) Extracts concentration/disc: disc 1 - μg/μL in the re-dissolved lyophilized extract at the final concentration, discs 2 and 3 - μg/μL in 50% and 25% dilutions of
the re-dissolved extract, respectively.
c) As reported in the ethnobotanical literature in Puerto Rico to exhibit antimicrobial properties.
d) As reported in ethnopharmacological survey in Puerto Rico as an adjuvant for diabetes.
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diffusion assay
The disc preparation was performed following the pro-
cedure outlined by the British Society for Antimicrobial
Chemotherapy in their Methods for Antimicrobial Sus-
ceptibility Testing Version 7, January 2008 [15]. A single
bacterial colony was removed from a streak plate ofTrypticase soy agar (TSA, BD Biosciences) and incu-
bated in Luria broth (LB, Difco) overnight with shaking
at 37°C. A bacterial suspension in 2 mL of distilled H2O
was prepared and adjusted to a density of 0.5 McFarland
units, which correspond to 1.5 × 108 CFU/mL. The
suspension was then plated onto Mueller-Hinton agar
(Difco), followed by disk deposition and incubation at
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measuring the diameter of the inhibition surrounding
each disc. The relative inhibition was calculated for each
extract and is represented as the percentage difference
of inhibition between the positive control (antibiotic)
and the extract. All of the experiments were performed
in triplicate.
Minimum inhibitory concentration (MIC) determination
The MIC is defined as the lowest concentration of anti-
microbial that can inhibit the visible growth of a micro-
organism after overnight incubation (British Society for
Antimicrobial Chemotherapy). Extracts that showed in-
hibition in the disc diffusion assay were further analyzed
according to the procedure of Velmonte et al. with some
modifications [16]. The bacterial species tested were S.
saprophyticus (ATCC 15305), S. aureus (ATCC 6341), P.
aeruginosa (ATCC 7700) and P. vulgaris (ATCC 6896).
MIC was determined for the extracts of Syzygium jambos,
Pityrogramma calomelanos, Tapeinochilus ananassae and
Gossypium barbadense. Stock solutions of lyophilized
aqueous extracts were serially diluted to obtain working
solutions with concentrations ranging from 2.0 to 0.003
mg/mL. Wells in a sterile 96-well plate were inoculated
with Luria Broth (LB) medium in the absence of bacteria
(blank control sample), bacteria with medium (positive
control sample), bacteria with medium and the extract
dilutions (experimental samples), background control
(samples consisting of medium with extract dilutions to
eliminate background extract absorbance), and bacteria
with Streptomycin at 10 mg/mL (negative control sam-
ples). Bacterial suspensions containing 5×104 CFU/mL of
Staphylococcus aureus (ATCC 6341), Staphylococcus
saprophyticus (ATCC 15305), Proteus vulgaris (ATCC
6896) or Pseudomonas aeruginosa (ATCC 7700) were
added to each well. The 96-well plates were incubated at
37°C for 18–20 hours. The absorbance at 625 nm was
measured for each plate using a microplate reader, and
background-subtracted with the background of the con-
trol (bacteria and medium). Then, the absorbance of the
extracts was compared to the absorbance of the positive
and negative control (Streptomycin 10 mg/mL) wells. The
MIC was the concentration in the wells that showed an
absorbance lower to the control well and that also gave a
p-value of 0.001 or less after statistical analysis.
Minimum bactericidal concentration (MBC) determination
The minimum bactericidal concentration (MBC) value is
defined as the extract concentration at which no bacter-
ial growth is observed in the agar nutrient plates, similar
to the negative control Streptomycin (10 mg/mL). The
effective concentration of the extracts in the experimen-
tal wells, as determined using the MIC assay, was used
to inoculate LB plates using a sterile swab and incubatedovernight at 37°C. Plates containing positive (bacteria
with medium) and negative (bacteria with 10 mg/mL
Streptomycin) controls for each bacterial species were
also prepared. The lowest concentration of the extract
at which no bacterial growth was observed was recorded
as the MBC. The MBC experiments were performed in
triplicate.
Statistical analysis
The inhibition data are presented as the percentage of
the positive control +/− SD. The MIC values are the
concentrations of each plant that were statistically sig-
nificant (value of 0.001 or less) compared with the con-
trol samples.
Results and discussion
The plant extracts listed in Table 1 were studied for
their antimicrobial activities against Staphylococcus
saprophyticus (ATCC 15305), Staphylococcus aureus
(ATCC 6341), Pseudomonas aeruginosa (ATCC 7700),
Proteus vulgaris (ATCC 6896), Escherichia coli (ATCC
4157), Haemophilus influenza (ATCC 8142), and the
fungus Candida albicans (ATCC 752). Of the 13 plant
extracts tested, data corresponding to the extracts that
showed microbial growth inhibition in the disc diffusion
assays will be discussed. These extracts include G.
barbadense fruit juice and the decoctions of P.
calomelanos, T. ananassae, and S. jambos (Figure 1).
The bacterial species inhibited by these extracts were S.
saprophyticus (ATCC 15305), S. aureus (ATCC 6341), P.
aeruginosa (ATCC 7700) and P. vulgaris (ATCC 6896).
Juice prepared from unripe G. barbadense fruit
exhibited more than 25% growth inhibition of the two
Gram-positive bacteria S. aureus (ATCC 6341) and S.
saprophyticus (ATCC 15305) relative to Streptomycin
treatment which showed 100% inhibition at 5 mg/mL. S.
aureus (ATCC 6341) has been isolated from the dis-
charge produced during an otitis media infection, which
provides a rationale for the use of G. barbadense juice
(juice from the unripe fruit) as an herbal remedy for this
infection [17]. The antimicrobial activity was observed at
a concentration of 7 mg/mL, the lowest concentration
tested (Figure 1A). The MIC values that were deter-
mined in this study for G. barbadense against S. aureus
(ATCC 6341) and S. saprophyticus (ATCC 15305) did
not meet the p-value of 0.001 or less used in our ana-
lyses. This result contrasts with a study of medicinal
plants from Yemen in which aqueous extracts from G.
barbadense were not active (MIC values > 1,000 μg/mL)
against S. aureus and E. coli and showed low activity
(MIC = 1000 μg/mL) against P. aeruginosa and other
bacterial strains [18]. In our study, no measureable MBC
was observed for either bacterial species. Treatment for
otitis media using herbal remedies has been very difficult.
Figure 1 Herbal remedies in the Caribbean that showed antimicrobial activities. Inhibition was calculated as percentages relative to the
positive control, Streptomycin- treated discs. A) G. barbadense juice; B) P. calomelanos decoction; C) T. ananassae decoction and D) S. jambos
decoction.
Table 2 MIC (p-value 0.001 or less) and MBC of extracts
that showed inhibition in the disc diffusion assaysa




T. ananassae P. aeruginosa 0.5 0.0002 NDb
P. vulgaris 0.5 0.0001 2.0
S. aureus 0.015 0.001 NDb
S. saprophyticus 2.0 0.0004 2.0
P. calomelanos P. aeruginosa 2.0 0.0001 NDb
S. jambos S. aureus 0.5 0.00001 1.0
S. saprophyticus 0.5 0.001 2.0
P. vulgaris 0.031 0.001 1.0
a) All the extracts that showed inhibition in the disc diffusion assay were
analyzed against the bacteria isolates S. saprophyticus (ATCC 15305), S. aureus
(ATCC 6341), P. aeruginosa (ATCC 7700) and P. vulgaris (ATCC 6896).
b) ND, Not detected.
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herb for infectious diseases, Echinacea purpurea roots and
seeds, did not show a decrease in the risk of otitis media
infection [19]. Nevertheless, naphthofuran analogues and
biologically active terpenoids from G. barbadense are
known to exhibit growth-inhibitory and antibacterial activ-
ities [20,21]. In addition, the essential oil has been reported
to show moderate activities against S. aureus, E. coli and
the fungus C. albicans [22]. Although the antimicrobial ac-
tivity in the oil might be due to the major components or
to synergy between major and minor components of the
oil, α-pinene, which is a terpene that comprises 12.8% of
the oil, has shown efficient antimicrobial properties.
The decoction of P. calomelanos (at the lowest con-
centration of 37.5 mg/mL) inhibited the growth of P.
aeruginosa (ATCC 7700), S. aureus (ATCC 6341) and S.
saprophyticus (ATCC 15305) by 2%-20% relative to
Streptomycin which showed 100% inhibition at 5 mg/
mL (Figure 1B). The MIC for P. aeruginosa (ATCC
7700) was 2 mg/mL (p = 0.0001); however, for S. aureus
(ATCC 6341) and S. saprophyticus (ATCC 15305), the
MIC values were not statistically significant (Table 2).
None of the concentrations that were tested showed
bactericidal activity. P. calomelanos is traditionally used
to treat kidney stones. The bacterium P. aeruginosa hasbeen associated with biofilm formation on kidney stones,
which leads to urinary infections [23]. The use of P.
calomelanos decoctions to treat kidney stones could be
related to the growth inhibition of P. aeruginosa, which
may justify the use of this treatment as an herbal medi-
cine. Studies that focused on several fern families have
demonstrated that ethanol and methanol extracts from
these plants exhibit antibacterial properties [24,25].
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latory antibiotic activity of the ethanol extract and the
methanolic fraction from the leaves of P. calomelanos
[26]. Neither preparation demonstrated antimicrobial ac-
tivity that was clinically relevant to fungi or bacteria
(MIC > 1024 μg/mL). However, in the modulation assay,
both extracts modulated most of the antibiotics tested
against S. aureus. The present study only tested aqueous
extracts as a way to validate the traditional remedies
employed by the surveyed population and is the first to
report the antimicrobial activities of P. calomelanos
decoctions. Phytochemical analysis of aqueous extracts
of P. calomelanos has revealed the presence of carbohy-
drates and coumarin [27]. Although data regarding the
specific antibiotic properties of coumarins are scarce,
antimicrobial activity against bacteria, fungi and viruses
has previously been reported for this class of phyto-
chemicals [3]. Conversely, polysaccharides are commonly
more effective as inhibitors of pathogen adsorption and
would not be identified in the screening techniques com-
monly used.
The decoction of T. ananassae at 15.3 mg/mL, the
lowest concentration tested, inhibited the growth of two
Gram-positive and two Gram-negative bacterial strains
by 22%-30% compared to the 100% inhibition of Strepto-
mycin at 5 mg/mL (Figure 1C). Specifically, the growth
inhibition values of P. aeruginosa (ATCC 7700), S.
saprophyticus (ATCC 15305), S. aureus (ATCC 6341)
and P. vulgaris (ATCC 6896) were 29%, 22%, 32% and
24%, respectively. The MIC values for T. ananassae were
0.5 mg/mL for P. aeruginosa (ATCC 7700), and P.
vulgaris (ATCC 6896) (p = 0.0002 and 0.0001, respect-
ively), 0.015 mg/mL for S. aureus (ATCC 6341) (p =
0.001) and 2.0 mg/mL for S. saprophyticus (ATCC
15305) (p = 0.0004) (Table 2). T. ananassae displayed
bactericidal activity against P. vulgaris (ATCC 6896) and
S. saprophyticus (ATCC 15305) at concentrations of 2.0
mg/mL for both species (Table 2). Our study showed
that T. ananassae inhibits the growth of pathogens asso-
ciated with opportunistic infections of burns and skin
infections such as P. aeruginosa and S. aureus, respect-
ively [28]. P. aeruginosa has become an important cause
of infection, especially in immunocompromised patients,
such as diabetic and cancer patients [29]. The antibiotic
activities of T. ananassae are important because people
with diabetes are vulnerable to infections as a result of
low blood flow to the extremities [30] and because of
certain types of neuropathy that cause dry and cracked
skin. Additional antimicrobial activity has been reported
for T. ananassae against the Gram-negative bacterium
Helicobacter pylori [31].
Decoctions of Syzygium jambos leaves inhibited S. aur-
eus (ATCC 6341) and S. saprophyticus (ATCC 15305) by
34% and 11%, respectively, at the lowest concentrationstudied (10.5 μg/μL) relative to Streptomycin which
showed 100% inhibition at 5 mg/mL. S. jambos at 20.9 mg/
mL also inhibited the Gram-negative P. vulgaris (ATCC
6896) by 24% relative to Streptomycin which showed 100%
inhibition at 5 mg/mL (Figure 1D). The MIC value for S.
aureus (ATCC 6341) and S. saprophyticus (ATCC 15305)
were 0.5 mg/mL (p = 0.00001 and 0.001, respectively), and
the MIC value for P. vulgaris (ATCC 6896) was 0.031 mg/
mL (p = 0.001) (Table 2). S. jambos was the only extract
that showed bactericidal activity against all of the isolates
that were tested. The MBC value for both S. aureus (ATCC
6341) and P. vulgaris (ATCC 6896) was 1.0 mg/mL, and
the MBC value for S. saprophyticus (ATCC 15305) was
2.0 mg/mL (Table 2). Previously, Lin et al. reported that
aqueous and acetone extracts from the bark of Syzygium
jambos had activity against several species of S. aureus
with MIC values that ranged from 0.50 to 0.75 mg/mL
and suggested that more active inhibitory compounds
are found in the leaves (0.21 to 0.83 mg/mL) than in the
bark [32]. Additionally, methanolic extracts of Syzygium
aromaticum showed inhibition against S. aureus, Sta-
phylococcus epidermidis, Streptococcus pyogenes, Sal-
monella enterica serovar Typhi and P. aeruginosa with
MICs ranging from 31.25-250 μg/mL [33]. We did not
find antimicrobial activity against P. aeruginosa, which
suggests that variation in the polarities of the extraction
solvents and the preparation methods used to make the
extracts that were studied may account for the differ-
ence in the activities of these two species.
For nearly all of the plant species that have significant
uses but that did not show antimicrobial activity, there
is evidence that their activity varies significantly with the
polarity and the concentration of the extracts, which in
turn determines the phytochemicals responsible for the
antibiotic effects [3,34]. For instance, the antimicrobial
effects of hydroalcoholic extracts from the leaves of
Plectranthus amboinicus have been reported against S.
aureus with a MIC of 9.3 mg/mL [35]. In another study
[36], seven out of ten S. aureus strains obtained from ex-
udates of otitis externa were sensitive to P. amboinicus
extracts at concentrations ranging from 1.25 to 5.0 mg/
mL. In particular, the essential oil of P. amboinicus was
active against two of the strains tested at 4% and 8% (w/
V). This result is noteworthy because the decoction,
which corresponds to the traditional preparation that is
used, significantly resembles the fraction obtained from
a steam distillation, which carries the essential oils that
would have been inactive in solution at the concentra-
tions obtained in this study (5.3 – 21.3 μg/μL). The au-
thors do not report the polarity of the extracts, although
the use of hydroalcoholic extracts was suggested.
The polar methanolic extracts from the leaves and
bark of Aristolochia trilobata showed activity against E.
coli with a MIC value of 2.5 mg/mL [37]. This MIC
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tions tested in this study, which were 3.22 and 3.53 mg/
mL for the stem and leaves, respectively. It is known that
methanol extractions are more exhaustive than those of
the aqueous or less polar organic and non-polar organic
solvents. Therefore, the compounds that are responsible
for the observed activity could be absent from the aqueous
decoctions. However, the authors previously reported that
the traditional use of this plant species has to be discour-
aged due to the mutagenic and possibly human carcino-
genic properties of the aristolochic acids present in the
methanol extracts and possibly in the water preparations
of aerial parts of the plant.
Serrulatane quinonoid biflorin, which is isolated from
the root tissue of Capraria biflora, has been reported to
exhibit antimicrobial activities against Gram-positive bac-
teria [38]. This activity is consistent with the traditional
use to treat conjunctivitis, which may be associated with
infections by S. aureus, S. epidermidis and Propionibacter-
ium spp., among others. Thus far, the activity of aqueous
extracts from the leaves has not been reported.
Aqueous extracts from the rhizomes of Costus speciosus
have been reported to exhibit antimicrobial activity against
S. aureus at a concentration of 200 mg/mL [39]. The re-
port describes the traditional system of administration
studied herein, but given that the concentrations tested in
our study varied from 11.8 – 47.3 μg/μL, a continuous ad-
ministration of the decoction would be required to explain
the traditional use for kidney infections.
Although there are several reports of the broad
spectrum antimicrobial activity of Cucurbita moschata
oil and seed extracts, no reports were found on the ac-
tivity of decoctions from the leaves [40]. Likewise, only
ethanol and acetone:ethyl acetate (1:1) extracts of the
aerial parts of H. rosa-sinensis have been studied previ-
ously [41,42]. The reported MIC and MBC values for
the ethanolic extract of the flowers against S. aureus
were 20 mg/mL. Thus, although the activities reported
indicate that antimicrobial compounds are present in
more polar solvents, higher concentrations than that
found in the traditional remedy are needed to assess the
antibacterial activity.
The results for Plantago major are similar to those de-
scribed above. That is, at a concentration of 2 mg/mL in
the hydroalcoholic extract, which is higher than those
found in the decoctions (7.2 – 28.7 μg/μL), the authors
reported MIC values of 1 mg/mL for S. aureus and > 1
mg/mL against E. coli, P. aeruginosa, C. albicans and
others [43]. Furthermore, the antibacterial properties of
lyophilized and fresh water extracts of Abelmoschus
esculentus were effective against all bacterial strains
tested, including S. aureus, E. coli and P. aeruginosa.
The fresh extract displayed better antibacterial proper-
ties than the lyophilized extract [44]. The MIC values forpeeled and unpeeled A. esculentus were 6.4 and 12.8 mg/
mL for S. aureus and P. aeruginosa, respectively. In this
case, the lipid fraction of A. esculentus was found to be
responsible for the antibacterial properties, whereas the
protein and polysaccharide fractions displayed no anti-
microbial activity. The concentration of the A. esculentus
decoction that was prepared in this study according to the
traditional use reported during the ethnopharmacological
survey was 12.6 mg/mL.
This study did not find antimicrobial activity that vali-
dates the traditional use of several herbal decoctions that
showed significant use during TRAMIL ethnopharma-
cological surveys. Two separate analyses, the disc diffu-
sion and the MIC assays, demonstrated that fewer than
33% of the herbal remedies that were examined exhibited
antibacterial activities. This result is not discouraging be-
cause several factors, in addition to those studied, could
determine the effectiveness of the extracts. First, the ex-
tracts could contribute to the treatment of disease, not ne-
cessarily by exerting an antibacterial response but by
promoting an anti-inflammatory response. This effect was
shown by Yang and collaborators, who demonstrated the
antimicrobial and anti-inflammatory properties of the es-
sential oils from Citrus sunki [45]. In addition, aqueous
extracts are typically less potent formulations than those
prepared with organic solvents such as methanol [46].
The solvent and the extraction system may modify the
final results as described in the study of Argemone
mexicana [47]. In this study, although the various solvent
extracts examined were effective, the methanolic extracts
showed maximum inhibition against the tested microor-
ganisms, followed by hot aqueous extracts and cold
aqueous extracts.
Conclusions
This study examined the inhibitory activity of Caribbean
herbal remedies, which are treatments that are generally
used by the surveyed populations for otitis media, kidney
stones, skin burns, fever and conjunctivitis, which are
associated with infections caused by Gram-positive and
Gram-negative bacteria. Considering that antimicrobials
are typically regarded as bactericidal if the MBC is nearly
four times the MIC, this study identified the novel bacteri-
cidal properties of T. ananassae and S. jambos decoctions,
which are commonly used as diabetes adjuvants in Puerto
Rico. The bactericidal activities of these preparations will be
extremely useful when treating patients with compromised
immune systems, such as diabetes patients. Additionally,
this article is the first report of the antimicrobial activities
of G. barbadense and P. calomelanos decoctions. The find-
ings that are reported here, which are the result of a screen
for the antimicrobial activities of traditional Caribbean
herbal remedies, will be presented to the TRAMIL program
to inform future TRADIF activities.
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